Xencor Reports Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Xencor (XNCR) Tops Q2 EPS by 18c, Revenues Beat
August 6, 2019 5:16 PM EDTXencor (NASDAQ: XNCR) reported Q2 EPS of ($0.28), $0.18 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $19.5 million versus the consensus estimate of $7.64 million.
Over the last two years, Xencor has initiated six Phase 1 clinical studies evaluating XmAb® bispecific antibodiesboth T cell engagers and tumor... More
